Skip to content

Clinical and strategy study on TCM treatments of pulmonary nodules based on state theory

Clinical and strategy study on TCM treatments of pulmonary nodules based on state theory

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003903
Enrollment
Unknown
Registered
2020-09-08
Start date
2020-09-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Nodules

Interventions

Sponsors

Dongfang Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of moderate risk pulmonary nodules. 2. Patients with stable pulmonary nodules on chest CT in recent 3 months. 3. Patients aged 35-80 years. 4. Patients who voluntarily sign informed consent will participate in clinical research voluntarily.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with sarcoidosis, tuberculosis or other infectious diseases. 2. Patients with serious primary diseases or tumor diseases such as cardio cerebrovascular, liver, kidney, blood, etc. 3. Patients with mental diseases such as mania, schizophrenia or other reasons can not cooperate with the observation and research. 4. Women planning pregnancy, pregnancy or lactation. 5. For the patients who are allergic to traditional Chinese medicine in this study, those who have allergic constitution or are allergic to many drugs.

Design outcomes

Primary

MeasureTime frame
The maximum diameter and maximum surface area of pulmonary nodules on CT scan;

Countries

China

Contacts

Public ContactXiaomei Zhang

Dongfang Hospital Beijing University of Chinese Medicine

zhangxim6767@sina.com+86 13651258013

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026